[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome

European Journal of Endocrinology

Volumn 152, Issue 4, 2005, Pages 521-525

  Markou, Athina ^a   Manning, Patrick ^a   Kaya, Banu ^a   Datta, Sam N ^a   Bomanji, Jamshed B ^a   Conway, Gerard S ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKERATIN; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; HYDROCORTISONE; PENTETREOTIDE IN 111; SYNAPTOPHYSIN; TESTOSTERONE; DIAGNOSTIC AGENT;

ADRENALECTOMY; ADULT; ARTICLE; BLOOD ANALYSIS; CANCER GROWTH; CANCER REGRESSION; CARCINOID; CASE REPORT; CUSHING SYNDROME; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYDROCORTISONE URINE LEVEL; IMMUNOHISTOCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; THORACOTOMY; THYMECTOMY; THYMUS CANCER; ECTOPIC HORMONE PRODUCTION; SCINTISCANNING; SECRETION; THYMOMA;

ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ADULT; CARCINOID TUMOR; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; PARANEOPLASTIC ENDOCRINE SYNDROMES; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; THYMECTOMY; THYMUS NEOPLASMS;

EID: 17744381182     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01839     Document Type: Article

References (27)

1. Tabarin A, Valli N, Chanson P, Bachelot Y, Rohmer V, Bex-Bachellerie V, Gatargi B, Roger P & Laurent F. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. Journal of Clinical Endocrinology and Metabolism 1999 84 1193-1202.
2. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler GB Jr & Loriaux DL. Petrosal sinus sampling with and without corticotrophin-releasing hormone for the differential diagnosis of Cushing's syndrome. New England Journal of Medicine 1991 325 897-905.
3. Landolt AM, Schubiger O, Maurer R & Girard J. The value of inferior petrosal sinus sampling in diagnosis and treatment of Cushing's disease. Clinical Endocrinology 1994 40 485-492.
4. Kaltsas GA, Giannulis MG, Newell-Price JD, Dacie JE, Thakkar C, Afshar F, Monson JP, Grossman AB, Besser GM & Trainer PJ. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. Journal of Clinical Endocrinology and Metabolism 1999 84 487-492.
5. Newell-Price J & Grossman AB. The differential diagnosis of Cushing's syndrome. Annals of Endocrinology 2001 62 173-179.
6. Case records of the Massachusetts General Hospital. A 20-year-old woman with Cushing's disease and a pulmonary module. New England Journal of Medicine 1987 317 1648-1658.
7. O'Brien T, Young WF Jr, Davila DG, Scheithauer BW, Kovacs K, Horvath E, Vale W & Van Heerden JA. Cushing's syndrome associated with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a pheochromocytoma. Clinical Endocrinology 1992 37 460-467.
8. Young J, Deneux C, Grino M, Oliver C, Chanson P & Schaison G. Pitfall of petrosal sinus sampling in a Cushing's syndrome secondary to ectopic adrenocorticotropin-corticotropin releasing hormone (ACTH-CRH) secretion. Journal of Clinical Endocrinology and Metabolism 1998 83 305-308.
9. Lefournier V, Martinie M, Vasdev A, Bessou P, Passagia JG, Labat-Moleur F, Sturm N, Bosson JL, Bachelot I & Chabre O. Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing's disease pituitary microadenoma: influence of catheter position and anatomy of venous drainage. Journal of Clinical Endocrinology and Metabolism 2003 88 196-203.
10. Soga J, Yakuwa Y & Osaka M. Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Review. Annals of Thoracic Cardiovascular Surgery 1999 5 285-291.
11. Perrot de M, Spiliopoulos A, Fischer S, Totsch M & Keshavjee S. Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome. Annals of Thoracic Surgery 2002 73 675-681.
12. Eriksson B, Arnberg H, Oberg K, Hellman U, Lundqvist G, Wernstedt C & Wilander E. A polyclonal antiserum against chromogranin A and B: a new sensitive marker for neuroendocrine tumors. Acta Endocrinologica 1990 122 145-155.
13. Grander D, Oberg K, Lundqvist ML, Janson ET, Eriksson B & Einhorn S. Interferon-induced enhancement of 2,5 oligoadenylate synthetase in mid-gut carcinoid tumors. Lancet 1990 336 337-340.
14. Krenning EP, Kooij PP, Bakker WH, Breeman WA, Postema PT, Kwekkeboom DJ, Oei HY, Dejong M, Visser TS & Reijs AE. Radiotherapy with a radiolabaled somatostatin analogue: a case history. Annals of the New York Academy of Sciences 1994 733 496-506.
15. Moertel CG, Johnson CM, McKusick MA, Martin JK Jr, Nagorney DM, Kvols LK, Rubin J & Kunselman S. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Annals of Internal Medicine 1994 120 302-309.
16. Ozawa Y, Tomoyasu H, Takeshita A, Shishiba Y, Yamada S, Kovacs K & Matsushita H. Shift from CRH to ACTH production in a thymic carcinoid with Cushing's syndrome. Hormone Research 1996 45 264-268.
17. Shikawa T, Inone C, Sasaki H, Saton K & Kimura N. Thymic carcinoid associated with ectopic ACTH syndrome. In Japanese. Nihoh Kyobu Shikkan Gakkai Zasshi 1996 34 471-476.
18. 18F-FDGPET/CT. Journal of Nuclear Medicine 2004 45 1340-1343.
19. Bomanji JB, Costa DC & Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncology 2001 3 157-164.
20. Eriksson B, Bergstrom M, Sundin A, Juhlin C, Orlefors H, Oberg K & Langstrom B. The role of PET in localization of neuroendocrine and adrenocortical tumors. Annals of the New York Academy of Sciences 2002 970 159-169.
21. Adams S, Baum R, Rink T, Schumm-Drager PM, Usadel KH & Hor G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumors. European Journal of Nuclear Medicine 2O01 25 79-83.
22. Erasmus JJ, McAdams HP, Patz EF, Coleman RE, Ahuja V & Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. American Journal of Roentgenology 1998 170 1369-1373.
23. Orlefors H, Sundin A, Ahlstrom H, Bjurling P, Bergstrom M, Lilja A, Langstrom B, Oberg K & Eriksson B. Positron emission tomography with 5-hydroxytryptophan in neuroendocrine tumors. Journal of Clinical Oncology 1998 16 2534-2541.
24. Mignon M. Natural history of neuroendocrine enteropancreatic tumors. Digestion 2000 62 51-58.
25. Sundin A, Eriksson B, Bergstrom M, Langsrom B, Oberg K & Orlefors H. PET in the diagnosis of neuroendocrine tumors. Annals of the New York Academy of Sciences 2004 1014 246-257.
26. Groves AM, Mohan HK, Wegner EA, Ham SF, Bingham SB & Clarke SE. PET with FDG to show thymic carcinoid. American Journal of Roentgenology 2O04 82 511-513.
27. Biering H, Pirlich M, Bauditz J, Sandrock D, Lochs H & Gerl H. PET scan in occult ectopic ACTH syndrome: a useful tool? Clinical Endocrinology 2003 59 404-405.